MaaT Pharma Revenue

Biotechnology Research • Lyon, Auvergne-Rhône-Alpes, France • 51-100 Employees

MaaT Pharma revenue & valuation

Annual revenue	$3,349,657
Revenue per employee	$41,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$10,800,000
Total funding	$61,400,000

Key Contacts at MaaT Pharma

Bastien Laperrousaz

Director Of Preclinical Development

Carole Schwintner

Chief Technology Officer

Anne Regairaz

R&D Project Director

Sophie Declomesnil

Pharmaceutical Development Director

Company overview

Headquarters	70 Avenue Tony Garnier, Lyon, 69007, FR
Phone number	+33428291400
Websites	maatpharma.com maat-pharma.com
NAICS	541714
Keywords	Oncology, Biotech, Pharma, Microbiology, Cancer, Microbiome, Leukemia, Microbiota, Blood Cancers, Symbiosis, Immune Modulation, Dysbiosis, Gut Microbiota, Gvhd, Gut Microbiome, Allo-Hsct
Founded	2014
Employees	51-100
Socials

MaaT Pharma Email Formats

MaaT Pharma uses 3 email formats. The most common is {first name}{last name} (e.g., johndoe@maat-pharma.com), used 90.9% of the time.

Format	Example	Percentage
{first name}{last name}	johndoe@maat-pharma.com	90.9%
{first initial}{last name}	jdoe@maat-pharma.com	5.5%
{2char}	{2char}@maat-pharma.com	3.6%

About MaaT Pharma

MaaT Pharma is a leading, late-stage clinical company focused on developing innovative gut microbiome-driven therapies to modulate the immune system and enhance cancer patient survival. Supported by a talented team committed to making a difference for patients worldwide, the Company was founded in 2014 and is based in Lyon, France. As a pioneer, MaaT Pharma is leading the way in bringing the first microbiome-driven immunomodulator in oncology. Using its proprietary pooling and co-cultivation technologies, MaaT Pharma develops high diversity, standardized drug candidates, aiming at extending life of cancer patients. MaaT Pharma has been listed on Euronext Paris (ticker: MAAT) since 2021.

Employees by Management Level

Total employees: 51-100

Seniority

Employees

Entry

Manager

Head

Employees by Department

MaaT Pharma has 43 employees across 10 departments.

Departments

Number of employees

Funding Data

Explore MaaT Pharma's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount
2021-08-20	9	$2,200,000
2024-06-15	23	$1,100,000
2025-04-27	14	$14,000,000
2025-08-28	16	$44,100,000

Funding Insights

$61,400,000

Total funding amount

$44,100,000

Most recent funding amount

Number of funding rounds

MaaT Pharma Tech Stack

Discover the technologies and tools that power MaaT Pharma's digital infrastructure, from frameworks to analytics platforms.

reCAPTCHA

Security

Material Design Lite

UI frameworks

lit-element

JavaScript libraries

Moove GDPR Consent

Cookie compliance

jQuery UI

JavaScript libraries

Animate.css

UI frameworks

lit-html

JavaScript libraries

jQuery Migrate

JavaScript libraries

Apache HTTP Server

Web servers

Twitter Emoji

Font scripts

jQuery

JavaScript libraries

PHP

Programming languages

Frequently asked questions

MaaT Pharma is located in Lyon, Auvergne-Rhône-Alpes, FR.

You can reach MaaT Pharma at +33428291400.

MaaT Pharma generates an estimated annual revenue of $3,349,657. This revenue figure reflects the company's market position and business performance in its industry.

MaaT Pharma has an estimated valuation of $10,800,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

MaaT Pharma was founded in 2014, making it 12 years old. The company has established itself as a significant player in its industry over this time.

MaaT Pharma has approximately 51-100 employees. The company continues to grow its workforce to support its business operations and expansion.

MaaT Pharma has raised a total of $61,400,000 across 4 funding rounds. This investment has helped the company grow and expand its operations.

Key Contacts at MaaT Pharma

Bastien Laperrousaz

Director Of Preclinical Development

Carole Schwintner

Chief Technology Officer

Anne Regairaz

R&D Project Director

Sophie Declomesnil

Pharmaceutical Development Director

4.8